Optic disc pit prevalence associated with glaucoma

Article

Optic disc pit prevalence increases with age and is strongly associated with high-pressure open-angle glaucoma.

Optic disc pit prevalence increases with age and is strongly associated with high-pressure open-angle glaucoma (OAG), according to a study published in the January/February issue of the Journal of Glaucoma.

Paul Healey and colleagues from the University of Sydney, Australia conducted a population-based, cross-sectional study of 3,654 persons aged 48 years or older. Stereo-optic disc photographs were graded in a masked fashion.

A total of nine pits were found in seven persons, a population prevalence of 0.19%. Four peripheral pits were found at the inferior pole, four central pits were located adjacent to the main vessel trunk and one pit was on the temporal disc margin. Pit prevalence increased with aged ([BETA]=0.0879, p=0.0099) and was found to be strongly associated with high-pressure OAG, peripapillary atrophy and optic disc haemorrhage. All peripheral pits were associated with paracentral visual field loss.

The results of this study suggest that optic disc pits are primarily associated with glaucoma and optic disc haemorrhage.

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.